GenSight Biologics S.A.
GSGTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $19 | $21 | $136 | $268 |
| - Cash | $2 | $2 | $11 | $44 |
| + Debt | $19 | $24 | $18 | $13 |
| Enterprise Value | $36 | $42 | $144 | $236 |
| Revenue | $2 | $1 | $3 | $5 |
| % Growth | 18.4% | -50.9% | -51.1% | – |
| Gross Profit | $2 | $1 | $3 | $5 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$11 | -$21 | -$27 | -$27 |
| % Margin | -757.9% | -1,648.8% | -1,036.9% | -515.5% |
| Net Income | -$14 | -$26 | -$28 | -$29 |
| % Margin | -933.4% | -2,069.5% | -1,069.9% | -542.4% |
| EPS Diluted | -0.17 | -0.54 | -0.6 | -0.63 |
| % Growth | 68.5% | 10% | 4.8% | – |
| Operating Cash Flow | -$13 | -$25 | -$34 | -$17 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$13 | -$25 | -$34 | -$17 |